Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the Fructose‐Fed Rats

  title={Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the Fructose‐Fed Rats},
  author={I-Hung Chen and Juei-Tang Cheng and Yat-Ching Tong},
  journal={LUTS: Lower Urinary Tract Symptoms},
To investigate the effect of metabolic syndrome on the bladder cannabinoid receptors 1 and 2 (CB1/CB2) expression and function in the fructose‐fed rats (FR). 
Recent Developments in Rodent Models of High-Fructose Diet-Induced Metabolic Syndrome: A Systematic Review
This review compiles and compares studies published in the past five years between the multitude of rodent comparative models and examines the response factors, niche parameters, and replicability of diet protocols to offer insight into MetS-related disease-specific modelling.
Urinary bladder enlargement across nine rodent models of diabetes: correlations with glucose and insulin levels
It is concluded that the presence and extent of bladder enlargement varies markedly across diabetes models, particularly TD2M models; the data do not support the idea that bladder enlargements is primarily driven by glucose levels/glucosuria.
Effects of fat-to-sugar ratio in excess dietary energy on lipid abnormalities: a 7-month prospective feeding study in adult cynomolgus monkeys
The findings suggest that not only excess dietary energy but also the balance of dietary fat-to-sugar ratio matters in diet-induced lipid abnormalities, and that HF exhibited stronger effects on lipid abnormalities than HS.
Tadalafil ameliorates bladder overactivity by restoring insulin-activated detrusor relaxation via the bladder mucosal IRS/PI3K/AKT/eNOS pathway in fructose-fed rats
Results suggest tadalafil may ameliorate MS-associated bladder overactivity by restoring insulin-activated detrusor relaxation via molecular mechanisms that are associated with preservation of IR/IRS/PI3K/AKT/eNOS pathway in the bladder mucosa and cGMP production in the urinary stream.


Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model
To investigate diabetes‐associated changes in urinary bladder expression of cannabinoid receptors 1 and 2 (CB1 and CB2) and the functional role of CB agonists and antagonists in mediating phasic
Metabolic Syndrome Enhances Prostate Contractility and In Vitro Phenylephrine‐induced α1‐Adrenoceptor Protein Expression in the Fructose‐fed Rat
The objective is to study the effects of metabolic syndrome on prostate α‐adrenergic contractile function using fructose‐fed rats (FR) and to establish an experimental protocol for this study.
Changes of urinary bladder contractility in high‐fat diet‐fed mice: The role of tumor necrosis factor‐α
To study the role of tumor necrosis factor‐α in bladder dysfunction associated with obesity, a large number of animals were slaughtered and the objective was to establish a histopathological profile of the cells that secrete TNFα, which is responsible for bladder dysfunction.
Urinary Bladder Relaxation through Activation of Imidazoline Receptors Induced by Agmatine is Increased in Diabetic Rats
The effect of agmatine on bladder contractility and the diabetes‐induced alteration of this action were studied in the rat and the results confirmed the importance of knowing the carrier and removal status of this substance in the menstrual cycle.
The orphan receptor GPR55 is a novel cannabinoid receptor
The endocannabinoid system functions through two well characterized receptor systems, the CB1 and CB2 receptors. Work by a number of groups in recent years has provided evidence that the system is
Distribution and function of the endocannabinoid system in the rat and human bladder
The endocannabinoid system is functionally expressed in both species, with CB1 receptors showing both pre- and postsynaptic inhibitory effects on rat bladder contraction, whereas CB2 acts only postsynaptically.
Overactive bladder: Is there a link to the metabolic syndrome in men?
The role of the autonomic nervous system and hyperinsulinemia in lower urinary tract symptoms, together with their implications for urological practice are explored.
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
A comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy is provided.